Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06360536 · ClinicalTrials.gov registry record · NA

Remotely Delivered Resistance Training for Cardiometabolic Health Among Black Women

A NA study of Overweight or Obesity and Resistance Training, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT06360536 is a NA study of Overweight or Obesity and Resistance Training that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 36 participants, below the 31,711-participant average among 32 other Overweight or Obesity trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06360536, a NA study of Overweight or Obesity and Resistance Training, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to collect preliminary data on the feasibility, acceptability, and potential effects of a novel, remotely delivered resistance training program.

Interventions

  • BEHAVIORAL Resistance Training

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2025-06-04
Est. Completion 2026-06-30
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT06360536

The ClinicalTrials.gov registry entry for NCT06360536 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 31,711-participant average among 32 other Overweight or Obesity trials with a reported enrollment target (100% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Overweight or Obesity appearing as the primary indexed condition, and to 1 intervention - of which Resistance Training is the first listed.

NCT06360536 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT06360536 about?

NCT06360536 is a clinical study titled "Remotely Delivered Resistance Training for Cardiometabolic Health Among Black Women". The purpose of this study is to collect preliminary data on the feasibility, acceptability, and potential effects of a novel, remotely delivered resistance training program.

What is the current status of trial NCT06360536?

This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2025-06-04. Estimated completion is 2026-06-30.

What conditions does trial NCT06360536 study?

This clinical trial studies the following conditions: Overweight or Obesity, Resistance Training, Prediabetes or Diabetes, Prehypertension (Elevated Blood Pressure) or Hypertension.

What interventions are being tested in trial NCT06360536?

The interventions under investigation include: Resistance Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT06360536?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06360536 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight or Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.